Market Research Logo

North America Gerd Drugs And Devices Market Forecast 2019-2026

North America Gerd Drugs And Devices Market Forecast 2019-2026

KEY FINDINGS

The North American market for GERD drugs and devices is the largest in the world and is supposed to grow with a 0.78% CAGR for the forecast years 2019-2027. The United States of America and Canada are taken into consideration for the market analysis in this report.

MARKET INSIGHTS

The rise in initiatives for awareness, education and funding for research on reflux and GERD are helping to proliferate the GERD drugs and devices market in the United States.

Canada GERD drugs and devices market is the largest contributor in the North American region. This particular disorder is found to be the most commonly occurring acid levels fluctuation malady in Canada. So, the level of raising awareness and preference of self-medication concerning GERD and other acid-related disorders are propelling the Canadian market growth.

COMPETITIVE INSIGHTS

Some of the key companies are focusing on newer products to increase their portfolio size are Abbott Laboratories, AstraZeneca, Ausch Health (Formerly Valeant Pharmaceuticals International, Inc.), Boston Scientific Corporation, Cempra Inc. (Merged with Melinta), Daewoong Co. Ltd., Eisai Inc., Glaxosmithkline, Ironwood Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer, Inc., RaQualia Pharma Inc. & Takeda Pharmaceuticals Company Ltd.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Antacids Drug Class Holds The Largest Market Share
3.2.2. Bravo System Devices Are Widely Used
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Growing Trend Of Self-medication
4.2.2. Increasing Awareness About Gerd
4.2.3. Increasing Occurrence Of Gerd Disorders
4.2.4. Changes In Lifestyle
4.3. Market Restraints
4.3.1. Patent Expiry
4.3.2. Adverse Effect Of Proton Pump Inhibitors And Other Drugs
4.3.3. Proton Pump Inhibitor Resistance
4.4. Market Opportunities
4.4.1. Increased Practice Of Generics And Otc Drugs
4.4.2. Cost-effective Otc Drugs
4.4.3. Overuse Of Medication And Dietary Supplements
4.5. Market Challenges
4.5.1. Use Of Complementary And Alternative Treatments
4.5.2. Probability Of Buying Counterfeit Drugs
4.6. Market By Drugs Dosage Form
4.7. Market By Route Of Administration Of Drugs
5. Market By Drugs And Devices
5.1. Drug Class
5.1.1. Antacids
5.1.2. H2 Receptor Blockers
5.1.3. Proton Pump Inhibitors (Ppi)
5.1.4. Pro-kinetic Agents
5.2. Devices
5.2.1. Digitrapper
5.2.2. Bravo System
5.2.3. Stretta
5.2.4. Linx Reflux Management System
5.2.5. Muse (Medigus Ultrasonic Surgical Endostapler) System
5.2.6. Other Devices
6. Key Analytics
6.1. Porter’s Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute
6.1.3. Bargaining Power Of Suppliers
6.1.4. Bargaining Power Of Buyers
6.1.5. Threat Of Competitive Rivalry
6.2. Pipeline Drugs
6.3. Regulatory Framework
6.4. Patent Analysis
6.5. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Abbott Laboratories.
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Astrazeneca
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bausch Health (Formerly Valeant Pharmaceuticals International, Inc.)
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Boston Scientific Corporation
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Cempra Inc. (Merged With Melinta)
8.2.5.1. Company Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Daewoong Co. Ltd.
8.2.6.1. Company Profiles
8.2.6.2. Product Portfolio
8.2.6.3. Strategic Initiatives
8.2.7. Eisai Inc
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Glaxosmithkline
8.2.8.1. Company Overview
8.2.8.2. Product Portfolio
8.2.8.3. Scot Analysis
8.2.8.4. Strategic Initiatives
8.2.9. Ironwood Pharmaceuticals, Inc.
8.2.9.1. Company Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Johnson & Johnson
8.2.10.1. Company Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Merck & Co., Inc.
8.2.11.1. Company Profiles
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Novartis
8.2.12.1. Company Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Pfizer, Inc.
8.2.13.1. Company Profiles
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Raqual Ia Pharma Inc.
8.2.14.1. Company Overview
8.2.14.2. Product Portfolio
8.2.14.3. Strategic Initiatives
8.2.15. Takeda Pharmaceuticals Company Limited
8.2.15.1. Company Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
List Of Table
Table 1 North America Gerd Drugs And Devices Market 2019-2027 ($ Million)
Table 2 North America Gerd Drugs And Devices Market By Drugs And Devices 2019-2027 ($ Million)
Table 3 North America Drug Class Market By Types 2019-2027 ($ Million)
Table 4 North America Drug Class Market 2019-2027 ($ Million)
Table 5 North America Antacids Market 2019-2027 ($ Million)
Table 6 North America H2 Receptor Blockers Market 2019-2027 ($ Million)
Table 7 North America H2 Receptor Blockers Market By Types 2019-2027 ($ Million)
Table 8 North America Proton Pump Inhibitors (Ppi) Market 2019-2027 ($ Million)
Table 9 North America Proton Pump Inhibitors (Ppi) Market By Types 2019-2027 ($ Million)
Table 10 North America Pro-kinetic Agents Market 2019-2027 ($ Million)
Table 11 North America Devices Market By Types 2019-2027 ($ Million)
Table 12 North America Devices Market 2019-2027 ($ Million)
Table 13 North America Digitrapper Market 2019-2027 ($ Million)
Table 14 North America Bravo System Market 2019-2027 ($ Million)
Table 15 North America Stretta (Mederitherapeutics) Market 2019-2027 ($ Million)
Table 16 North America Linx® Reflux Management System (Torax Medical) Market 2019-2027 ($ Million)
Table 17 North America Muse™ (Medigus Ultrasonic Surgical Endostapler) System Market 2019-2027 ($ Million)
Table 18 North America Other Devices Market 2019-2027 ($ Million)
Table 19 North America Gerd Drugs And Devices Market 2019-2027 ($ Million)
Table 20 North America Gerd Drugs And Devices Market By Country 2019-2027 ($ Million)
List Of Figures
Figure 1 North America Gerd Drugs And Devices Market By Geography 2019-2027 ($ Million)
Figure 2 North America Gerd Drugs And Devices Market Share By Drugs And Devices 2017 & 2027 (%)
Figure 3 Porter’s Five Force Model
Figure 4 North America Gerd Drugs And Devices Market Regional Outlook 2018 & 2027 (%)
Figure 5 The United States Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 6 Canada Gerd Drugs And Devices Market 2019-2027 ($ Million)
Figure 7 Gerd Ppis Drugs Provider Company Market Share 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report